CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

Rafael de la Camara
  • Rafael de la Camara
    > Hospital de la Princesa > C/Diego de León nº 62 > Madrid 28006 > Spain > > JRCAMARA@telefonica.net, Spain | JRCAMARA@telefonica.net

Abstract

Due to its negative impact in the outcome of stem cell transplant (SCT) and solid organ transplant patients (SOT) CMV has been called “the troll of transplantation”. One of the greatest advances in the management of SCT has been the introduction of the preemptive strategy. Since its introduction, the incidence of the viremia, as expected, remains unchanged but there has been a marked decline in the incidence of early CMV disease. But in spite of the advances in prevention of CMV disease, CMV is still today an important cause of morbidity and mortality. Late CMV disease is still occurring in a significant proportion of patients and the so-called indirect effects of CMV are causing significant morbidity and mortality. Fortunately, there have been several advances in the development of new antivirals, adoptive immunotherapy and DNA-CMV vaccines that might transform the management of CMV in the near future. 

Keywords

Hematopoietic Stem Cell Transplantation; Cytomegalic Infection

Full Text:

PDF
HTML
Submitted: 2016-05-16 22:59:59
Published: 2016-06-20 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1316

Views:
PDF
404
HTML
1643

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185